Ihre Präferenzen wurden für diese Sitzung aktualisiert. Um Ihre Account-Einstellungen dauerhaft zu ändern, gehen Sie zu
Zur Erinnerung: Sie können Ihr bevorzugtes Land oder Ihre bevorzugte Sprache jederzeit in
>
Klicken Sie hier, um unsere Erklärung zur Barrierefreiheit anzuzeigen
checkoutarrow
DE

Zurück zu Pressemitteilungen

iHerb Announces Confidential Submission of Draft Registration Statement

22 July 2021
Confidential Submission

PR Newswire, 22 July 2021 

iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.

About iHerb: We are the world’s largest eCommerce platform dedicated to the Vitamins, Minerals, Supplements, or VMS, category, with a growing presence in other areas of consumer health and wellness. Trusted by millions in over 185 countries, we offer a curated portfolio of branded and innovative third-party and proprietary products at the best possible value, conveniently delivered directly to our customers.

Contacts 

Nicole Rohrer

Director, Brand and Content

[email protected]

Cassandra Bujarski/Steven Goldberg

Sard Verbinnen & Co.

[email protected]

Alle Pressemitteilungen anzeigen